An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy
Journal: Nano Letters
Published: 2020-06-11
DOI: 10.1021/acs.nanolett.0c00953
Affiliations: 5
Go to articleInstitutions | Share |
---|---|
University of Wisconsin-Madison (UW-Madison), United States of America (USA) | 0.95 |
Yonsei University, South Korea | 0.05 |